These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4549 related items for PubMed ID: 628002

  • 1. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ, Loo TL.
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA, Townsend LB.
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [Abstract] [Full Text] [Related]

  • 3. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ, Hansch C, Kim KH, Milstein SR, Schmidt CL, Smith RN, Quinn FR.
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T, D'Incalci M.
    Cancer Chemother Pharmacol; 1984 Jun; 13(2):139-41. PubMed ID: 6467499
    [Abstract] [Full Text] [Related]

  • 5. 1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Farquhar D, Benvenuto J.
    J Med Chem; 1984 Dec; 27(12):1723-7. PubMed ID: 6502603
    [Abstract] [Full Text] [Related]

  • 6. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
    Wilman DE, Goddard PM.
    J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J, Catherall EJ, Cockburn A.
    Cancer Chemother Rep; 1973 Sep; 57(3):263-8. PubMed ID: 4751253
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional-group modifications of dextran for linkage to a diazonium group. A potential vehicle for tumour targeting of antineoplastic triazenes.
    Baki AV, Vaughan K.
    Carbohydr Res; 1982 Jul 01; 105(1):57-68. PubMed ID: 6180830
    [Abstract] [Full Text] [Related]

  • 10. New dimeric analogues of ethidium; synthesis, interaction with DNA, and antitumor activity.
    Kuhlmann KF, Mosher CW.
    J Med Chem; 1981 Nov 01; 24(11):1333-7. PubMed ID: 7310810
    [Abstract] [Full Text] [Related]

  • 11. Psychotropic drugs as potential antitumor agents: a selective screening study.
    Driscoll JS, Melnick NR, Quinn FR, Lomax N, Davignon JP, Ing R, Abott BJ, Congleton G, Dudeck L.
    Cancer Treat Rep; 1978 Jan 01; 62(1):45-74. PubMed ID: 23898
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1.
    Yamato M, Takeuchi Y, Hashigaki K, Ikeda Y, Chang MR, Takeuchi K, Matsushima M, Tsuruo T, Tashiro T, Tsukagoshi S.
    J Med Chem; 1989 Jun 01; 32(6):1295-300. PubMed ID: 2542558
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of DTIC (NSC-45388) in animals.
    Venditti JM.
    Cancer Treat Rep; 1976 Feb 01; 60(2):135-40. PubMed ID: 1260771
    [No Abstract] [Full Text] [Related]

  • 14. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
    Carter SK, Friedman MA.
    Eur J Cancer (1965); 1972 Feb 01; 8(1):85-92. PubMed ID: 4552317
    [No Abstract] [Full Text] [Related]

  • 15. 1,3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents.
    Smith RH, Scudiero DA, Michejda CJ.
    J Med Chem; 1990 Sep 01; 33(9):2579-83. PubMed ID: 2391696
    [Abstract] [Full Text] [Related]

  • 16. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G, Giraldi T, Lassiani L, Nisi C.
    Cancer Res; 1984 Jan 01; 44(1):64-8. PubMed ID: 6690062
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of antitumor activity of 1-[N, N-bis(2-chloroethyl) sulfamoylphenyl]-3,3-dialkyltriazenes.
    Lalezari I, Afghahi F.
    J Pharm Sci; 1975 Apr 01; 64(4):698-9. PubMed ID: 1142087
    [Abstract] [Full Text] [Related]

  • 18. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I, Woodman RJ, Gang M, Cysyk RL, Venditti JM.
    Cancer Chemother Rep; 1973 Apr 01; 57(3):291-8. PubMed ID: 4751255
    [No Abstract] [Full Text] [Related]

  • 19. Experimental studies at Southern Research Institute with DTIC (NSC-45388).
    Montgomery JA.
    Cancer Treat Rep; 1976 Feb 01; 60(2):125-34. PubMed ID: 1260770
    [Abstract] [Full Text] [Related]

  • 20. Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.
    Lin YT, Loo TL.
    J Med Chem; 1972 Feb 01; 15(2):201-3. PubMed ID: 5008242
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 228.